LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,323 | +50.0% | 22,082 | +80.5% | 0.09% | +51.7% |
| Q2 2023 | $882 | +42.7% | 12,237 | +45.7% | 0.06% | +20.8% |
| Q1 2023 | $618 | -99.9% | 8,400 | +147.1% | 0.05% | -61.6% |
| Q3 2018 | $933,000 | +32.5% | 3,400 | 0.0% | 0.12% | +17.9% |
| Q2 2018 | $704,000 | +25.3% | 3,400 | 0.0% | 0.11% | +19.1% |
| Q1 2018 | $562,000 | – | 3,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |